Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. (Q54541278)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. |
scientific article |
Statements
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. (English)
1 reference
Ignace Vergote
1 reference
Frederic Amant
1 reference
Walter H Gotlieb
1 reference
Suresh Advani
1 reference
Chanchal Goswami
1 reference
Hal Hirte
1 reference
Diane Provencher
1 reference
Naresh Somani
1 reference
S Diane Yamada
1 reference
Jean-Francois Tamby
1 reference
20 December 2011
1 reference
13
1 reference
2
1 reference
154-162
1 reference
Identifiers
1 reference